International Journal of Tuberculosis and Lung Disease

Article	Citations
TB infection in adults with diabetes mellitus in Uganda	223
Clinical profile and outcomes of paediatric central nervous system tuberculomas	118
TB-related deaths among adults in Guinea-Bissau	99
Launch of a second wave of IJTLD Clinical Standards for Lung Health	71
The absence of evidence of cure is not a risk for recurrent TB among patients treated for TB	50
Ethambutol-induced optic neuropathy: should we mandate ophthalmic examination in TB treatment?	44
Dr Christopher Zishiri	40
Travel reimbursements, distance to health facility and preventive treatment cascade for drug-resistant TB	38
The impact of sputum quality on Xpert positivity in active case-finding for TB	36
Screening of refugees from Ukraine for TB: a TBnet survey	29
Decentralising DOT for drug-susceptible TB from the health facilities to the community level in Togo	28
WHO target product profiles for TB preventive treatment	27
Reply to ‘Estimating TB survival ‐ mind the immortal-time gap’	26
Atorvastatin to reduce bacillary load and attenuate lung damage in TB patients	26
The effect of antenatal isoniazid preventive therapy on birth outcomes in Western Kenya	24
Targeted therapeutic drug monitoring identifies frequent under-dosing of TB drugs	23
Cost-effectiveness of pretomanid-based regimen for highly drug- resistant TB in a low-burden setting	22
CAD4TB software updates: different triaging thresholds require caution by users and regulation by authorities	21
Latent TB and depressive symptoms in household contacts of persons with active TB	21
Improving access to affordable quality-assured inhaled medicines in low- and middle-income countries	20
TB in ageing populations: lessons from Japan and Korea	19
Use of a molecular bacterial load assay to distinguish between active TB and post-TB lung disease	19
The COVID-19 pandemic does not bode well for TB control	18
Lichenoid drug eruption in patients on anti-TB therapy in a high HIV prevalence setting	17
Haematological indicators of mortality in people with community-acquired pneumonia living at high altitude	17

Are schools prepared to manage students with an asthma attack?	16
Literature Highlights	16
Reply to: Observations on malnutrition and anti-TB drugs in Ghana	16
Gender differences in health-seeking behaviour, diagnosis and treatment for TB	15
Assessment of TB patient cost – what about the mitigation strategy?	15
Standards for clinical trials for treating TB	15
Assessing patient satisfaction with video-supported therapy for drug-susceptible TB treatment	14
Occupational transmission of TB infection during autopsy	13
Impact of revised definitions for extensively drug-resistant TB on disease classification	13
Accessibility and TB patient satisfaction in Nigeria	13
Sputum culture conversion definitions and analytic practices for multidrug-resistant TB	13
TB testing in HIV-positive patients prior to antiretroviral treatment	13
Treatment outcomes and safety of bedaquiline, delamanid, and linezolid in multidrug-resistant TB	12
Perceived stigma among people with TB and household contacts	12
TB disease yield from household contact screening of TB index patients in Pakistan	12
Advantages and limitations of virtual multi-disciplinary team meetings on difficult-to-treat mycobacteria	12
Introduction of the Simple One-Step stool Xpert Ultra method to detect TB in children and adults	12
Performance of spirometry assessment at TB diagnosis	12
Risk factors for severe COPD exacerbation in Chinese adults	11
Clinical standards for the diagnosis and management of asthma in low- and middle-income countries	11
Prevalence of chronic airflow obstruction in sub-Saharan Africa	11
Higher yield using an event-based vs. door-to-door approach for active case-finding for TB	11
A cohort study exploring variables associated with mortality in critically ill TB patients	11
A novel method for contact tracing for TB at household and community level	10
Paediatric TB care in the United Kingdom	10
Factors associated with false-negative for T-SPOT.TB in patients with TB disease	10
Opportunities to prevent and manage undernutrition to amplify efforts to end TB	10
Does distance to healthcare facility affect care-seeking for TB-related symptoms in Tanzania?	10
Patterns of TB transmission in the United States, 2011–2017	10
Incidence of TB among kidney transplant recipients in a setting with universal isoniazid prophylaxis	10
Updated guidelines for child and adolescent TB	9
Post-TB lung disease: keep going beyond TB!	9
Facilitators and barriers to adolescent participation in a TB clinical trial	9
Population attributable fraction for smoking and diabetes in TB	9
Emphasis on post-TB lung disease and other sequelae of TB is good but a public health approach to TB is morally ambitious	9
Initial experience with BPaL-based regimens to treat multidrug-resistant TB	8
Health status of Italian children living close to cultivations sprayed with pesticides	8
Perceived stigma related to TB preventive therapy	8
EJ-antisynthetase syndrome presenting as severe acute respiratory distress syndrome	8
Bedaquiline-based all-oral regimen for macrolide-resistant Mycobacterium abscessus pulmonary disease	8
Impact of COVID-19 on extrapulmonary TB and the benefit of decentralised TB services	8
Epidemiology and clinical characteristics of childhood TB identified using active and passive case finding	8
TB case fatality and recurrence in a private sector cohort in Mumbai, India	8
Cascade of care for people with TB and diabetes in India	8
The household economic burden of drug-susceptible TB diagnosis and treatment in The Gambia	7
Population pharmacokinetics of bedaquiline in patients with drug-resistant TB	7
Medical management of large and multiple pulmonary echinococcal cysts	7
Protecting healthcare workers from TB	7
Epidemiology, detection, diagnosis and treatment of TB in children in Kazakhstan	7
Lower TB notification rates in later life in the same birth cohort, Japan, 1950–2020	7

The effect of systematic screening of the general population on TB case notification rates	7
Meeting of two pandemics in prison: a challenging event in a challenging environment	7
Use of computed tomography for the diagnosis of TB during a paediatric outbreak	7
Clinical features, microbiology and lung function in post-TB bronchiectasis compared to other aetiologies	7
Mortality and causes of death in non-tuberculous mycobacterial pulmonary disease	7
Characteristics, risk factors and outcomes of critically ill patients with active TB	7
TB therapeutic drug monitoring – analysis of opportunities in Romania and Ukraine	7
Post-hospitalisation respiratory and physical functions in patients with SARS-CoV-2 delta	7
Evaluation of QFT-Plus performance using blood samples stored at room temperature	7
An approach for improving the quality of country-level TB modelling	7
Clinical experience of TB in patients treated with anti-TNF-α	6
Pulmonary TB and chronic pulmonary aspergillosis: clinical differences and similarities	6
If you want to go far, go together: standardisation and data sharing in TB drug development	6
TB and chronic pulmonary aspergillosis: a few relevant points	6
Community-based intervention and health education to scale up TB preventive treatment for children	6
Predictors of TB disease in HIV-exposed children from Southern Africa	6
Urine LAM diagnostics can close the deadly testing gap for TB	6
A new understanding of clinical patterns in post-TB lung disease	6
TB prevalence among pregnant women with HIV in Rio de Janeiro, Brazil	6
Financial impact of COVID-19 on TB patients in India	6
Cost of TB prevention and treatment in the Philippines in 2017	6
Real-world implementation of video-observed therapy in an urban TB program in the United States	6
Rifampicin-resistant TB: discordance between Xpert® MTB/RIF and MTBDRplus results	6
Effect of biological therapies on TB treatment outcomes	6
Paediatric formulations for the treatment of drug resistant TB: closing the gaps	6
Evaluation of testing face-mask filter samples with LAMP shows high rates of detection in pulmonary TB	6
Supplementary inspired oxygen fraction is a simple clinical tool that predicts clinical deterioration	6
Prevalence and determinants of chronic respiratory diseases in adults in rural Sudan	6
Contribution of Xpert® MTB/RIF to pediatric TB diagnosis in Mozambique	6
TB notifications among citizens and non-citizens in Taiwan	6
Guidance is needed to mitigate the consequences of analytic errors during antimicrobial susceptibility testing for TB	6
Towards quality adolescent-friendly services in TB care	6
A scoping review of interventions to mitigate common non-communicable diseases among people with TB	6
Impact of COVID-19 on hospitalisations for asthma	6
Extemporaneously compounded liquid formulations of clofazimine	6
The high costs facing TB-affected households in Mali	6
WHO drug-resistant TB guidelines 2022: what is new?	5
A systematic review on the effect of diabetes mellitus on the pharmacokinetics of TB drugs	5
Glutathione and N-acetylcysteine in TB management	5
Diabetes characteristics and long-term management needs in diabetic TB patients	5
Estimating TB survival ‐ mind the immortal-time gap	5
Determinants of treatment outcomes in patients with multidrug-resistant TB	5
TB and COVID-19 co-infection in a pulmonology hospital	5
Chronic pulmonary aspergillosis as a sequel to pulmonary TB	5
Early line-probe assay using DNA specimens in patients with pulmonary TB	5
After DOT, the brave new world?	5
New diagnostics for the spectrum of asymptomatic TB: from infection to subclinical disease	5
Use of stool swabs in molecular transport media increases access to Xpert Ultra testing for TB in children	5
High prevalence of multidrug-resistant TB among household contacts in a high burden setting	5
Responding to the post-pandemic crisis: post-exposure prophylaxis for TB	5
Population attributable fraction for undernutrition due to TB does not take account of bidirectional causality	5
Time to integrate epidemiological and economic models for TB	5
Cutaneous adverse drug reactions to fixed-dose combination treatments for TB	5
Fluoroquinolone preventive therapy for children exposed to MDR-TB	5
Literature Highlights	5
A home-based care programme for rifampicin-resistant TB	5
National approaches to TB care in adolescents	5
TB mortality in low-incidence countries: can we reduce it further?	5
Sputum pooling for rapid and cost-effective active case-finding for TB in prisons	5
Rapid molecular diagnostics to detect resistance to second-line anti-TB drugs	5
Bronchiectasis exacerbations: certainties and future challenges	5
Exhaled breath specimens subjected to point-of-care lipoarabinomannan testing	5
TB disease in children from the prehistoric era	5
TB screening of Ukrainian refugees in Germany	5
A bold new future for the IJTLD	5
Quality assessment of clinical practice guidelines for the management of wheezing disorders in children	5
An epidemiological analysis of TB trends in native and migrant populations, New Mexico, 1993–2021	5
The rise of artificial intelligence reading of chest X-rays for enhanced TB diagnosis and elimination	4
Establishing proof of concept for utility of Trueprep®-extracted DNA in line-probe assay testing	4
Lessons learned from treating drug-resistant TB and how to apply these to drug-susceptible TB	4
Implementation of modified, all-oral shorter TB regimens in Armenia	4
Dactylitis due to accidental needle-stick injury with a BCG-loaded syringe	4
Evidence and ethical considerations for the treatment of contacts exposed to drug-resistant TB	4
Family directly observed therapy for children with drug-resistant TB	4
Is it time for new fixed-dose combinations and revised weight bands for children with drug-susceptible TB?	4
Interventions to enhance treatment adherence and retention in care for HIV-TB	4
Diabetes mellitus and TB – finding strategies to reduce the double burden of disease	4
Pretomanid with bedaquiline and linezolid for drug-resistant TB: a comparison of prospective cohorts	4
Metabolic characterisation of adult Ugandan patients with TB and diabetes mellitus comorbidity	4
Early mortality during rifampicin-resistant TB treatment	4

Factors associated with presenting to private sector care providers at the onset of TB symptoms	4
TB screening, prevention and treatment cascade in a Malawi prison	4
TB screening of children from Ukraine in Germany	4
Use of rapid molecular TB diagnostics for incarcerated people in Brazil	4
Prevalence of and risk factors for depressive symptoms in non-tuberculous mycobacterial pulmonary disease	4
Impact of the COVID-19 pandemic on TB infection testing	4
Geographical differences in chronic obstructive pulmonary disease mortality trends by sex, Spain, 1980–2021	4
Efflux pump gene expression study using RNA-seq in multidrug-resistant TB	4
A study of persistent symptoms and pulmonary function at 3 months post moderate or severe COVID-19 in Angola	4
Approaches and processes for paediatric chest X-ray classification used in the SHINE TB treatment-shortening trial	4
Evaluation of the MolecuTech® REBA MTB-XMDR kit for detection of pre-extensively drug-resistant TB	4
Launch of the IJTLD Clinical Standards for Lung Health	4
Post-TB bronchiectasis: clinical characteristics and microbiology	3
Isolation and purification of lipoarabinomannan from urine of adults with active TB	3
Long-term follow-up of persons diagnosed with multidrug-resistant TB in Chennai, India, 2013–2020	3
Factors associated with referrals for directly observed treatment and unsuccessful treatment	3
A comprehensive person-centred TB care model, from malnutrition to mental health	3
Outcomes of childhood TB in countries with a universal BCG vaccination policy	3
Household air pollution and COPD: cause and effect or confounding by other aspects of poverty?	3
The effect of TB patient delay on loss to follow-up in Portugal	3
National survey on the impact of the war in Ukraine on TB diagnostics and treatment services in 2022	3
Therapeutic drug monitoring for isoniazid and rifampicin exposure	3
Highlighting the characteristics of TB disease in older people	3
TB in the elderly: clinical features and outcomes	3
Factors associated with patient delay in the diagnosis of TB – a study of health-seeking behaviour	3
Characterising cause of death among people treated for drug-susceptible TB in India	3
Nosocomial TB in two neonatal intensive care units at a tertiary care centre: infection risk and outcomes	3
Introduction of new drugs for drug-resistant TB in Iraq	3
Culture-negative TB: clinical characteristics, risk factors and treatment outcomes	3
Predictive value of neutrophil-to-lymphocyte ratio in severe pulmonary infection: sex-specific cut-off values needed	3
Poor dietary intake at hospital admission is a predictor of mortality in patients with COVID-19	3
SMaRT-PCR: sampling using masks and RT-PCR, a non-invasive diagnostic tool for paediatric pulmonary TB	3
Prevalence and determinants of chronic respiratory diseases in adults in Sudan	3
Bridging the gap: key evidence needed to strengthen global policies to end TB	3
Stable, compounded bedaquiline suspensions to support practical implementation of pediatric dosing in the field	3
Clinical outcomes in comorbid COVID-19 and TB cases	3
The economic burden of TB-affected households in DR Congo	3
Concomitant pulmonary disease is common among patients with extrapulmonary TB	3
TB in older people in Asia: why it is important	3
Outcomes for people with TB by disease severity at presentation	3
Risk factors for the isolation of Haemophilus influenzae in patients with stable chronic obstructive pulmonary disease	3
Increasing trend of non-tuberculous mycobacteria in a Croatian hospital, 2012–2019	3
Successful rechallenge of rifabutin in rifampicin-induced thrombocytopenia during TB treatment	3
Impact of Rv0678 mutations on patients with drug-resistant TB treated with bedaquiline	3
Ocular TB in Western Australia	3
Risk factors in ICU patients with initial acquisition of carbapenemase-resistant Klebsiella Pneumoniae	3
The urgent need to improve on low implementation rates for TB preventive treatment for people living with HIV	3
TB and interstitial lung disease: a systematic review and meta-analysis	3
Attrition in the treatment cascade among elderly patients with multidrug-resistant TB	3
The scientific response to TB – the other deadly global health emergency	3
First report of multidrug-resistant M. tuberculosis Beijing strain isolated from the indigenous population in Tunisia	3
Impact of COVID-19 on diagnosis and testing for TB in a high-resource, low-burden setting	3
The 100th anniversary of bacille Calmette-Guérin (BCG) and the latest vaccines against COVID-19	3
Work-related interstitial lung diseases: reassessing the burden	3
Stool-based Xpert testing for diagnosis of TB in children and critically ill adults	3
Time to care-seeking for TB symptoms	3
Eosinophils in bronchiectasis: searching for a new endotype	3
Identifying gaps in the cascade of care for latent TB infection in a low-incidence setting	3
Outcomes of WHO-conforming, longer, all-oral multidrug-resistant TB regimens and analysis implications	3
Contribution of post-infectious bronchiolitis obliterans to non-cystic fibrosis bronchiectasis in children	3
Electronic nicotine delivery system use among current smokers in India	3
Conjugated hyperbilirubinemia associated with accidental rifapentine overdose	3
Chronic respiratory disease in adult outpatients in three African countries: a cross-sectional study	3
Programmatic implications of a sub-national TB prevalence survey in India	3
Outcomes of TB contact tracing and predictors of success: a 10-year retrospective cohort analysis in Birmingham, UK	3
Factors associated with screening failure and study withdrawal in multidrug-resistant TB	3
Preventive treatment for MDR-TB exposure in households	3
A non-invasive, sensitive assay for active TB: combined cell-free DNA detection and FluoroSpot assays	2
Tackling the many layers of stigma is essential for the “End TB Strategy”	2
Cash transfers to enhance completion of TB screening among household contacts in rural Tanzania	2
Disability is a risk factor for 1-year mortality after TB diagnosis	2
Cost of TB services in healthcare facilities in Kenya (No 3)	2
Clinical standards for the management of adverse effects during treatment for TB	2
Response to: The pressing need for standardised diagnostic criteria for obstructive ventilatory impairment in adults and children	2
Successes and challenges of latent TB screening and treatment in a high-prevalence US region	2
Evaluation of a lateral-flow nanoparticle fluorescence assay for TB infection diagnosis	2
Improving enrolment for TB preventive treatment	2
Use of local data to evaluate TB contact investigation in Malawi	2
Low rifampicin levels in plasma associated with a poor clinical response in patients with abdominal TB	2
Household drug-resistant TB contact tracing in Tajikistan	2
Quantification of multidrug-resistant M. tuberculosis bacilli in sputum during the first 8 weeks of treatment	2
A systematic review of the costs of diagnosis for multidrug-resistant/extensively drug-resistant TB in different settings	2
A randomised controlled trial to evaluate a medication monitoring system for TB treatment	2
Pediatric TB treatment outcomes: targets for improvement	2
Adequacy of WHO weight-band dosing and fixed-dose combinations for the treatment of TB in children	2
Geographic mobility and time to seeking care among people with TB in Limpopo, South Africa	2
An update on the IJTLD: our latest impact factor and influence on policy-making	2
Prospective evaluation of thin-layer agar colour test in routine diagnosis of multidrug-resistant TB	2
Why are people still dying from TB in low-burden countries?	2
Clinical utility of target-based next-generation sequencing for drug-resistant TB	2
Parental TB associated with offspring asthma and rhinitis	2
Low serum levels of anti-TB drugs in a high TB setting	2
The cascade of care for household contacts of people with drug-resistant TB	2
Evaluation of point-of-care algorithms to detect diabetes during screening for latent TB infection	2
A model for integrating social protection measures with TB control in Pakistan	2